Page 6 - 202012

Efficacy and Safety of Shengxuening Tablets in the Treatment of Cancer-related Anemia：A Meta-analysis ……
…………………………………………… LI Chunlu，HUANG Feihong，YE Yun，WU Jianming，ZOU Wenjun（1494）
Systematic Review of Methodological Guidelines for Health Technology Assessment at Home and Abroad ……
………………………………………………………………………………………………………… XU Peipei，
LI Wenrui，ZENG Linan，LIU Dan，ZHANG Yang，MI Xue，HUANG Zongyao，SONG Haoxin，ZHANG Lingli（1500）
Meta-analysis of the Efficacy and Safety of Prophylactic Use of Low-dose Aspirin in Patients with Chronic
Renal Disease ………………………………………………… QIU Sha，WANG Na，XIANG Jing，QIAN Yan（1506）
Participation of Clinical Pharmacists in Pharmaceutical Care for a Child with Subglottic Talaromyces marneffei

Infection …………………………………… CHEN Yinqing，WU Weizhe，HE Yanling，HE Fan，CEN Hanjing（1511）

CHINA PHARMACY （Semimonthly） Postal Address
Founded in January 1990 129 Daping Main Street，Yuzhong District，Chongqing
Vol.31，No.12，Jun. 2020 400042，China
Total No.678 Published on Jun. 30，2020 Phone
Responsible Institution 86-23-63830521；86-23-63830907
National Health Commission，P.R. China E-mail
Sponsored by info@china-pharmacy.com
Chinese Hospital Association Website
Chongqing University Cancer Hospital http：//www.china-pharmacy.com
Edited by Online Submission
China Pharmacy Editorial and Publishing Center http：//2018.china-pharmacy.com
Director of Editorial Commission Printed by
LI Linkang Chongqing Changhong Printing Co.，Ltd.
Executive Deputy Director of Editorial Commission Distributed by
WU Yongzhong China：Chongqing Post Offices（Code No.78-33）
Honorary Editor-in-Chief Overseas：China International Book Trading Corporation
MA Jin （Code No.4703SM）
Editor-in-Chief Subscription Rates
HU Xin US $ 8.00 per issue；US $ 192.00 per annum
Vice Editor-in-Chief CSSN ISSN 1001-0408
LENG Huaiming CN 50-1055/R
Chief Editor CODEN
ZHANG Jian ZYHAA4
Published by Perennial Legal Counsel
China Pharmacy Editorial Department Chongqing Huali Wantao Law Firm